Ventas raises 2026 guidance on SHOP growth and $5.2 billion in investments
Ventas reported a 10% rise in Q3 normalized FFO per share to $0.99 and lifted its full-year 2026 guidance, according to a TradingView summary.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
According to TradingView, Ventas (VTR) posted third-quarter normalized FFO per share up 10% to $0.99. Cash NOI from the same-store SHOP senior housing portfolio climbed 16%.
Year to date the company has put $5.2 billion into senior housing investments, which supported a higher forecast for fiscal 2026, even though interest rates and currency moves weighed on results.
why it matters
For investors, the story shows that operating growth and active capital deployment are helping this healthcare REIT offset higher financing costs. Rate and currency pressures remain the key risks to watch across the sector.
market impact
VTR shares and healthcare REITs: stronger earnings and raised guidance support the stock
- Ventas (VTR) shares pressure up — higher FFO and a raised forecast support investor interest
tags
instruments
sources
- VTR: SHOP growth and $5.2 billion of YTD investments lifted earnings and FY guidance — TradingView, 27 October 2026 at 20:34 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗